PSTI
Price:
$1
Market Cap:
$40.85M
Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also d...[Read more]
Industry
Biotechnology
IPO Date
2007-12-10
Stock Exchange
NASDAQ
Ticker
PSTI
According to Pluristem Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.53. This represents a change of 73.99% compared to the average of 0.30 of the last 4 quarters.
The mean historical Current Ratio of Pluristem Therapeutics Inc. over the last ten years is 5.80. The current 0.53 Current Ratio has changed 807.39% with respect to the historical average. Over the past ten years (40 quarters), PSTI's Current Ratio was at its highest in in the September 2015 quarter at 11.50. The Current Ratio was at its lowest in in the December 2024 quarter at 0.
Average
5.80
Median
5.96
Minimum
0.68
Maximum
9.30
Discovering the peaks and valleys of Pluristem Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 87.70%
Maximum Annual Current Ratio = 9.30
Minimum Annual Increase = -88.32%
Minimum Annual Current Ratio = 0.68
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.68 | -88.32% |
| 2021 | 5.85 | -3.59% |
| 2020 | 6.07 | 87.70% |
| 2019 | 3.23 | -13.75% |
| 2018 | 3.75 | -30.07% |
| 2017 | 5.36 | -13.05% |
| 2016 | 6.16 | -32.98% |
| 2015 | 9.20 | 9.75% |
| 2014 | 8.38 | -9.92% |
| 2013 | 9.30 | 34.51% |
The current Current Ratio of Pluristem Therapeutics Inc. (PSTI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.20
5-year avg
3.92
10-year avg
5.80
Pluristem Therapeutics Inc.’s Current Ratio is less than Magenta Therapeutics, Inc. (17.35), less than Rein Therapeutics Inc. (0.90), less than Eyenovia, Inc. (2.25), less than Satsuma Pharmaceuticals, Inc. (6.75), less than Lumos Pharma, Inc. (2.66), greater than Lunai Bioworks Inc. (0.04), less than GreenLight Biosciences Holdings (2.01), less than Cerecor Inc. (12.44), less than LianBio (74.19), less than AlloVir, Inc. (12.89),
| Company | Current Ratio | Market cap |
|---|---|---|
| 17.35 | $42.44M | |
| 0.90 | $36.54M | |
| 2.25 | $38.59M | |
| 6.75 | $36.47M | |
| 2.66 | $37.54M | |
| 0.04 | $32.92M | |
| 2.01 | $45.43M | |
| 12.44 | $38.63M | |
| 74.19 | $11.68M | |
| 12.89 | $49.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pluristem Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pluristem Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Pluristem Therapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for Pluristem Therapeutics Inc. (PSTI)?
What is the highest Current Ratio for Pluristem Therapeutics Inc. (PSTI)?
What is the 3-year average Current Ratio for Pluristem Therapeutics Inc. (PSTI)?
What is the 5-year average Current Ratio for Pluristem Therapeutics Inc. (PSTI)?
How does the current Current Ratio for Pluristem Therapeutics Inc. (PSTI) compare to its historical average?